About
Nanological develops a diagnostic device that enables ultra-rapid identification of sepsis-causing pathogens directly from blood samples using optomechanical detection and artificial intelligence, without the need for culture or labeling.
Explore Nanological's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.